Д.Мягмарцэрэн
Loading...
Товч нэр
Д.Мягмарцэрэн
Бүтэн нэр
Дашцэрэн Мягмарцэрэн
Латин нэр
Dashtseren Myagmartseren
Албан тушаал
Тэнхимийн эрхлэгч
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
Харьяалал
5 results
Now showing 1 - 5 of 5
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Association Between Consumption of Sugar-sweetened Beverages and Childhood Obesity and Overweight(Mongolian National University of Medical Sciences, 2016-11-25); ;Khorolmaa Bold ;Altantuya Batmunkh; Objectives: This paper aims to study how consumption of beverages relates to the body weight of children and adolescents in Mongolia. Methods: A cross sectional survey was conducted between 2015 and 2016. A group of 353 relatively healthy children and adolescents aged 6-16 were selected from ger districts of Ulaanbaatar, Mongolia. Descriptive statistics were used to summarize the data. Chi-squared analysis was conducted to evaluate the association of categorical variables with body mass index (BMI) z-score subgroups. T-test or two-way ANOVA was performed to compare means. Beverage consumption was presented as means with standard deviation (SD) among sex and age groups. Results: The data from 347 children and adolescents were analyzed. Boys represented 50.1% (n =174) and the mean age ± SD was 10.0 ±2.9 years. Tea was the main beverage type in all age and sex groups compared to other types of beverages. Girls aged between 10 and 13 years old had the highest consumption of sugar-sweetened beverages (SSB). And there was a markedly high consumption of SSB among overweight and obese children. Conclusion: Significantly higher consumption of SSB was seen among overweight and obese children. Detailed household and school-based observational and interventional studies should be performed using these findings to help policy makers to make evidence-based decisions about SSB. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Knowledge of the adverse effects of smoking and related changes in smoking status during pregnancy among female smokers: a survey in Ulaanbaatar, Mongolia(Taylor & Francis, 2023-03-23); ; ;Batgerel Oidov ;Baigalmaa LuvsandagvaSmoking during pregnancy causes various health problems in pregnant women and their newborns. We aimed to clarify the association between smoking behavior during pregnancy and knowledge about health risks associated with active and passive smoking during pregnancy among women smokers prior to pregnancy. We conducted a questionnaire survey among women in Ulaanbaatar, Mongolia between October and December 2018. Of the 220 women who received the questionnaire, 200 (90.9%) responded; however, due to incomplete data, 49 participants were excluded. Among the 151 participants included in the study, 80 (53.0%) actively smoked during and 71 (47.0%) quit smoking directly before pregnancy. A significant difference in the knowledge of the health risks associated with active smoking between both groups was found (P < 0.001). The likelihood of smoking cessation during pregnancy was higher in women who were more knowledgeable about the health risks of active smoking than in those who were less knowledgeable (odds ratio, 3.824; 95% confidence interval: 1.594–9.171). The prevalence of smoking during pregnancy was associated with a lack of knowledge of the health risks of active smoking. Therefore, measures should be taken to ensure that women are adequately advised about the maternal and fetal health risks associated with smoking during pregnancy and subsequently promote the well-being of both the mother and infant. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey(Elsevier BV, 2021-12); ; ;Le, Linh-Vi; BACKGROUND: With the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020, Mongolia implemented rapid emergency measures and did not report local transmission until November 2020. We conducted a national seroprevalence survey to monitor the burden of SARS-CoV-2 in Mongolia in the months surrounding the first local transmission. METHODS: During October-December 2020, participants were randomly selected using age stratification and invited for interviews and blood samples at local primary health centres. We screened for total SARS-CoV-2 antibodies, followed by two-step quantitative SARS-CoV-2 IgG serology tests for positive samples. Weighted and test-adjusted seroprevalences were estimated. We used chi-square, Fisher's exact and other tests to identify variables associated with seropositivity. FINDINGS: A total of 5000 subjects were enrolled. We detected SARS-CoV-2 IgG antibodies in 72 samples. Crude seroprevalence of SARS-CoV-2 antibodies was 1·44% (95%CI,1·21-1·67). Population weighted and test-adjusted seroprevalences were 1·36% (95%CI,1·11-1·63) and 1·45% (95%CI,1·11-1·63), respectively. Age, sex, geographical, and occupational factors were not associated with seropositivity (p>0·05). Symptoms and signs within past 3 months and seropositivity were not associated at the time of the survey (p>0·05). INTERPRETATION: SARS-CoV-2 seroprevalence in Mongolia was low in the first year of the pandemic potentially due to strong public health measures, including border restrictions, educational facilities closure, earlier adoption of mask-wearing and others. Our findings suggest large-scale community transmission could not have occurred up to November 2020 in Mongolia. Additional serosurveys are needed to monitor the local pandemic dynamic and estimate how far from herd immunity Mongolia will be following-up with vaccination programme in 2021 and 2022. FUNDING: World Health Organisation, WHO UNITY Studies initiative, with funding by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health (BMG) COVID-19 Research and development. TRANSLATION: Cyrillic and Traditional Mongolian translation of abstract is available on appendix section.Scopus© Citations 14 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, SARS-CoV-2 seroepidemiology in Mongolia, 2020-2021: a longitudinal national study(Elsevier BV, 2023-04); ;Bailie, Christopher R; ;Price, David JBACKGROUND: The COVID-19 pandemic has global impacts but is relatively understudied in developing countries. Mongolia, a lower-middle-income country, instituted strict control measures in early 2020 and avoided widespread transmission until vaccines became available in February, 2021. Mongolia achieved its 60% vaccination coverage goal by July 2021. We investigated the distribution and determinants of SARS-CoV-2 seroprevalence in Mongolia over 2020 and 2021. METHODS: We performed a longitudinal seroepidemiologic study aligned with WHO's Unity Studies protocols. We collected data from a panel of 5000 individuals in four rounds between October 2020 and December 2021. We selected participants through local health centres across Mongolia by age-stratified multi-stage cluster sampling. We tested serum for the presence of total antibodies against SARS-CoV-2 receptor-binding domain, and levels of anti-SARS-CoV-2 spike IgG and neutralising antibodies. We linked participant data with national mortality, COVID-19 case, and vaccination registries. We estimated population seroprevalence and vaccine uptake, as well as unvaccinated population prior-infection prevalence. FINDINGS: At the final round in late 2021, 82% (n = 4088) of participants completed follow-up. Estimated seroprevalence increased from 1.5% (95% CI: 1.2-2.0), to 82.3% (95% CI: 79.5-84.8) between late-2020 and late-2021. At the final round an estimated 62.4% (95% CI: 60.2-64.5) of the population were vaccinated, and of the unvaccinated population 64.5% (95% CI: 59.7-69.0) had been infected. Cumulative case ascertainment in the unvaccinated was 22.8% (95% CI: 19.1%-26.9%) and the overall infection-fatality ratio was 0.100% (95% CI: 0.088-0.124). Health workers had higher odds for being COVID-19 confirmed cases at all rounds. Males (1.72 (95% CI: 1.33-2.22)) and adults aged 20 and above (12.70 (95% CI: 8.14-20.26)) had higher odds for seroconverting by mid-2021. Among the seropositive, 87.1% (95% CI: 82.3%-90.8%) had SARS-CoV-2 neutralising antibodies by late 2021. INTERPRETATION: Our study enabled tracking of SARS-CoV-2 serological markers in the Mongolian population over one year. We found low SARS-CoV-2 seroprevalence in 2020 and early 2021, with seropositivity increasing over a 3-month interval in 2021 due to vaccine roll out and rapid infection of most of the unvaccinated population. Despite high seroprevalence in Mongolia amongst both vaccinated and unvaccinated individuals by end-2021, the SARS-CoV-2 Omicron immune escape variant caused a substantial epidemic. FUNDING: World Health Organization, WHO UNITY Studies initiative, with funding by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health (BMG) COVID-19 Research and development. The Ministry of Health, Mongolia partially funded this study.Scopus© Citations 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Comparison of Three Diagnostic Definitions of Metabolic Syndrome and Estimation of Its Prevalence in Mongolia(2023-03); ;Haruyama, Yasuo ;Takaoka, Nobuko ;Takahashi, KyoDashdorj, NaranjargalWe sought to estimate the prevalence of metabolic syndrome (MS) in the urban population of Mongolia and suggest a preferred definition. This cross-sectional study comprised 2076 representative samples, which were randomly selected to provide blood samples. MS was defined by the National Cholesterol Education Program's Adults Treatment Panel III (NCEP ATP III), the International Diabetes Federation (IDF), and the Joint Interim Statement (JIS). The Cohen's kappa coefficient (κ) was analyzed to determine the agreement between the individual MS components using the three definitions. The prevalence of MS in the 2076 samples was 19.4% by NCEP ATP III, 23.6% by IDF, and 25.4% by JIS criteria. For men, moderate agreement was found between the NCEP ATP III and waist circumference (WC) (κ = 0.42), and between the JIS and fasting blood glucose (FBG) (κ = 0.44) and triglycerides (TG) (κ = 0.46). For women, moderate agreement was found between the NCEP ATP III and high-density lipoprotein cholesterol (HDL-C) (κ = 0.43), and between the JIS and HDL-C (κ = 0.43). MS is highly prevalent in the Mongolian urban population. The JIS definition is recommended as the provisional definition.Scopus© Citations 6
